Antibiotic Sensitivity of Staphylococcus Aureus. Past and Present

  • R. P. Mouton
Part of the New Perspectives in Clinical Microbiology book series (NPCM, volume 4)


The history of resistance of Staphylococcus aureus to antibiotics is almost as old as the use of antibiotics itself: Barber [1], in 1947, described a therapeutic failure in a staphylococcal infection due to penicillin-resistance. Penicillinase production was soon found to be the cause of this resistance [2]. Later it became evident that the gene responsible for penicillinase production is located in a plasmid [3].


Staphylococcus Aureus Resistance Rate Fusidic Acid Staphylococcal Infection Methicillin Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barber M: Staphylococcal infection due to penicillin-resistant strains. Brit Med J 2: 863, 1947.PubMedCrossRefGoogle Scholar
  2. 2.
    Barber M: Coagulase positive staphylococci resistant to penicillin. J Pathol Bacteriol 59: 373, 1947.CrossRefGoogle Scholar
  3. 3.
    Morse ML: Transduction by staphylococcal bacteriophage. Proc Nat Acad Sci USA 45: 722, 1959.PubMedCrossRefGoogle Scholar
  4. 4.
    Smith JMB, Marples MJ: A natural reservoir of penicillin-resistant strains of Staphylococcus aureus. Nature 201: 844, 1964.PubMedCrossRefGoogle Scholar
  5. 5.
    Kayser FM, Wust J, Corrodi P: Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Ag Chemother 2: 217, 1972.CrossRefGoogle Scholar
  6. 6.
    Novick RP, Bouanchaud D: Extrachromosomal nature of drug resistance in Staphylococcus aureus. Ann N Y Acad Sci 182: 279, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Finland M, Haight TH: Antibiotic resistance of pathogenic staphylococci. AMA Archives of Internal Medicine 91: 1. 43, 1953.CrossRefGoogle Scholar
  8. 8.
    Hinton NA, Orr JH: Studies on the incidence and distribution of antibiotic-resistant staphylococci. J Lab Clin Med 49 (2): 566, 1957.PubMedGoogle Scholar
  9. 9.
    Goodier TEW, Parry WR: Sensitivity of clinically important bacteria to six common antibacterial substances. Lancet i: 356, 1959.CrossRefGoogle Scholar
  10. 10.
    Kooy P: Voor antibiotica ongevoelige staphylococcen in een ziekenhuis. Ned T Geneesk 100: 2524, 1956.Google Scholar
  11. 11.
    Petersdorf RG, Rose MC: The sensitivity of hemolytic staphylococci to a series of antibiotics. II: A three-year progress report. AMA Archives of Internal Medicine 105: 398, 1960.CrossRefGoogle Scholar
  12. 12.
    Fisher MW: The susceptibility of staphylococci to chloramphenicol. AMA Archives of Internal Medicine 105: 413, 1960.CrossRefGoogle Scholar
  13. 13.
    Knörr K, Wallner A: Möglichkeiten zur Bekämpfung des Staphylokokken-Hospitalismus. Dtsch Med Wschr 82: 1473, 1957.PubMedCrossRefGoogle Scholar
  14. 14.
    Bulger RJ, Evans Roberts C, Sherris JC: Changing incidence of antibiotic resistance among Staphylococcus aureus, E. colt, Aerobacter, Klebsiella and Pseudomonas encountered in a teaching hospital over a seven year period. Antimicrob Ag Chemother 1966: 42, 1967.Google Scholar
  15. 15.
    Ridley M, Lynn R, Barrie D, Stead KC: Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies. Lancet i: 230, 1970.CrossRefGoogle Scholar
  16. 16.
    Ayliffe AJ: Trends in resistance and their significance in primary pathogenic bacteria. In: Recent Advances in Infection ( Reeves D and Geddes A, eds.), Churchill Livingstone, Edinburgh, London and New York, 1979, p. 1.Google Scholar
  17. 17.
    Jevons MP: ‘Celbenin’-resistant staphylococci. Brit Med J I:124, 1961.CrossRefGoogle Scholar
  18. 18.
    Cetin ET: Staphylococci resistant to methicillin. Brit Med J II 51, 1962.CrossRefGoogle Scholar
  19. 19.
    Sjöström JE, Löfdahl S, Philipson L: Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol 123: 905, 1975.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Kayser FM, Wust J, Corrodi P: Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicr Ag Chemother 2: 217, 1972.CrossRefGoogle Scholar
  21. 21.
    Lacey RW, Grindsted J: Genetic analysis of methicillin-resistant strains of Staphylococcus aureus; evidence for their evolution from a single clone. J Med Microbiol 6: 511, 1973.PubMedCrossRefGoogle Scholar
  22. 22.
    Annear DI, Baron-Hay GS: Loss of resistance to methicillin and other antibiotics in Staphylococcus aureus associated with a chronic empyema. Med J of Australia i: 339, 1976.Google Scholar
  23. 23.
    Richmond MH, Parker MT, Jevons MP: High penicillinase production correlated with multiple antibiotic resistance in Staphylococcus aureus. Lancet i: 293, 1964.CrossRefGoogle Scholar
  24. 24.
    Knox R: Celbenin-resistant staphylococci. Brit Med J 1: 126, 1961.CrossRefGoogle Scholar
  25. 25.
    Barber M: Naturally occurring methicillin-resistant staphylococci. J Gen Microbiol 35: 183, 1964.PubMedCrossRefGoogle Scholar
  26. 26.
    Bulger RJ: In vitro studies on highly resistant small colony variants of staphylococcus aureus resistant to methicillin. J Infect Dis 120 (4): 491, 1969.PubMedCrossRefGoogle Scholar
  27. 27.
    Dyke KGH, Jevons MP, Parker MT: Penicillinase production and intrinsic resistance to penicillins in Staphylococcus aureus. Lancet i: 835, 1966.CrossRefGoogle Scholar
  28. 28.
    Churcher GM: A screening test for the detection of methicillin-resistant staphylococci. J Clin Pathol 21: 213, 1968.PubMedCrossRefGoogle Scholar
  29. 29.
    Parker MT, Hewitt JH: Methicillin resistance in Staphylococcus aureus. Lancet i: 800, 1970.Google Scholar
  30. 30.
    Bülow P: Staphylococci in Danish hospitals during the last decade: factors influencing some properties of predominant epidemic strains. Ann N Y Acad Sci 182: 21, 1971.PubMedCrossRefGoogle Scholar
  31. 31.
    Kayser FH, Mak TM: Methicillin-resistant staphylococci. Am J Med Sci 264 (3): 197, 1972.PubMedGoogle Scholar
  32. 32.
    Mouton RP, Van Boven CP: Tegen methicilline resistente Staphylococcus aureus-infecties in Nederland. Ned T Geneesk 113 (3): 131, 1969.Google Scholar
  33. 33.
    Michel MF, Priem CC: Control at hospital level of infections by methicillin-resistant staphylococci in children. J Hyg, Camb 69: 453, 1971.Google Scholar
  34. 34.
    Crossley K: An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. J Infect Dis 139 (3): 237, 1979.Google Scholar
  35. 35.
    Rosendal K, Jesson O, Bentzon MW, Bülow P: Antibiotic policy and spread of Staphylococcus aureus in Danish hospitals (1969–1974). Acta pathologica scandinavica Section B, 85: 143, 1977.Google Scholar
  36. 36.
    Lacey RW: Can methicillin-resistant trains of Staphylococcus aureus be treated with methicillin? Lancet i: 88, 1974.CrossRefGoogle Scholar
  37. 37.
    Rountree PM, Beard MA: Hospital strains of Staphylococcus aureus, with particular reference to methicillin resistant strains. Med J Aust 2: 1163, 1968.PubMedGoogle Scholar
  38. 38.
    Benner EJ, Kayser FH: Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet ii: 741, 1968.CrossRefGoogle Scholar
  39. 39.
    Chabbert YA: Behavior of ‘methicillin heteroresistant’ staphylococci to cephaloridine. Postgrad Med J 43 (Suppl.): 40, 1967.PubMedGoogle Scholar
  40. 40.
    Sabath LD, Barrett FF, Wilcox C, Gerstein DA, Finland M: Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. Antimicr Ag Chemother 1968: 302, 1969.Google Scholar
  41. 41.
    Siebert WT, Moreland N, Williams TW: Methicillin-resistant Staphylococcus epidermidis. South Med J 71 (11): 1353, 1978.PubMedCrossRefGoogle Scholar
  42. 42.
    Laverdière M, Peterson P, Verhoef J, Williams DN, Sabath LD: In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci. J Infect Dis 137 (3): 245, 1978.PubMedCrossRefGoogle Scholar
  43. 43.
    John JF Jr., McNeill WF: Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci. Minimal effect of beta-lactamase. Antimicr Ag Chemother 17 (2): 179, 1980.CrossRefGoogle Scholar
  44. 44.
    Archer GL, Tenenbaum MJ: Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery. Antimicr Ag Chemother 17 (2): 269 1980.CrossRefGoogle Scholar
  45. 45.
    Benner EJ, Bennett JV, Brodie JL, Kirby WMM: Inactivation of cephalothin and cephaloridine by Staphylococcus aureus. J Bacteriol 90 (6): 1599, 1965.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Kabins SA, Cohen S: Cephaloridine therapy as related to renal function. Antimicr Ag Chémother 5: 922, 1965.Google Scholar
  47. 47.
    Falkow S: The staphylococcal plasmids. In: Infectious Multiple Drug Resistance, Pion Ltd., London, 1975.Google Scholar
  48. 48.
    Kayser FH, Felix M, Wüst J: Extrachromosomal and chromosomal drug resistance in methicillin resistant Staphylococcus aureus. In: Bacterial Plasmids and Antibiotic Resistance, ( Krcméry V, Rosival L, Watanabe T, eds.), Spinger-Verlag, New York, 1972, p. 371.CrossRefGoogle Scholar
  49. 49.
    Kayser FH: Methicillin-resistant staphylococci. Lancet ii: 650, 1975.CrossRefGoogle Scholar
  50. 50.
    Mouton RP, Glerum JH, van Loenen AC: Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens — a seven-year survey. J Antimicr Chemother 2: 9, 1976.CrossRefGoogle Scholar
  51. 51.
    Steigbigel NH, Reed CW, Finland M: Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci 255: 179, 1968.PubMedCrossRefGoogle Scholar
  52. 52.
    Krcméry V, Grunt J, Rosival L, Calpass S: Antibiotic resistance in various medical services. Infection 7 (2): S216, 1979.PubMedCrossRefGoogle Scholar
  53. 53.
    Phillips I: Antibiotic policies. In: Recent Advances in Infection ( Reeves D, Geddes A, eds.), Churchill Livinstone, Edinburgh London and New York; 1979, p. 151.Google Scholar
  54. 54.
    Lacey RW: Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. Bact Rev 39: 1, 1975.PubMedGoogle Scholar
  55. 55.
    Bentley DW, Hahn JJ, Lepper MH: Transmission of chloramphenicol-resistant Staphylococcus epidermidis: Epidemiologic and laboratory studies. J. Infect Dis 122: 365, 1970.PubMedCrossRefGoogle Scholar
  56. 56.
    Shaw WV, Brodsky RF: Characterization of chloramphenicol acetyltransferase from chloramphenicol resistant Staphylococcus aureus. J Bacteriol 95: 28, 1968.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Lacey RW: Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus. J Clin Pathol 30: 602, 1977.PubMedCrossRefGoogle Scholar
  58. 58.
    Grinsted J, Lacey RW: Generic variation of streptomycin-resistance in clinical strains of Staphylococcus aureus. J Med Microbiol 6: 351. 1973.PubMedCrossRefGoogle Scholar
  59. 59.
    Mouton RP, Hos JM: Sensitivity of Staphylococcus aureus to lincomycins in relation to erythromycin and methicillin sensitivity. In: Advances in Antimicrobial and Antineoplastic Chemotherapy, ( Hejzlar M, Semonskÿ M, Madâk D, eds.), Urban & Schwarzenberg, München Berlin Wien, 1972, p. 623.Google Scholar
  60. 60.
    Lilly HA, Lowbury EJL: Antibiotic resistance of Staphylococcus aureus in a burns unit after stopping routine prophylaxis with erythromycin. J Antimicr Chemother 4 (6): 545, 1978.CrossRefGoogle Scholar
  61. 61.
    Hudson DG, Yoshihara GM, Kirby WMM: Spiramycin: clinical and laboratory studies. AMA Arch Int Med 97: 57, 1956.CrossRefGoogle Scholar
  62. 62.
    Brown DFJ, Kayser FH, Biber J: Gentamicin resistance in Staphylococcus aureus. Lancet ii: 419, 1976.CrossRefGoogle Scholar
  63. 63.
    Shannon KP, Phillips I: Gentimicin-resistant Staphylococcus aureus. Lancet ii: 580, 1976.CrossRefGoogle Scholar
  64. 64.
    Scott DF, Wood DO, Brownell GH, Carter MJ, Best GK: Aminoglycoside modification by gentamicin-resistant isolates of Staphylococcus aureus. Antimicr Agents Chemother 13: 641, 1978.CrossRefGoogle Scholar
  65. 65.
    Devaud M, Kayser FH, Huber U: Resistance of bacteria to the newer aminoglycoside antibiotics: an epidemiological and enzymatic study. J Antibiotics XXX: 655, 1977.CrossRefGoogle Scholar
  66. 66.
    Noble WC, Naidoo J: Evolution of antibiotic resistance in Staphylococcus aureus: the role of the skin. Br J Dermatol 98: 481, 1978.PubMedCrossRefGoogle Scholar
  67. 67.
    Starkey DH, Gregory E: Fluctuations in antibiotic resistances of gramnegative rods in one hospital, 1961–70, with comment on kanamycin-neomycin relationship. CMA 105: 587, 1971.Google Scholar
  68. 68.
    Lowbury EJL, Babb JR, Brown VI, Collins BJ: Neomycin-resistant Staphylococcus aureus in a burns unit. J Hygiene, Cambr 62: 221, 1964.Google Scholar
  69. 69.
    Rountree PM, Beard MA: The spread of neomycin resistant staphylococci in a hospital. Med J Australia i: 498, 1965.Google Scholar
  70. 70.
    Wyatt TD, Ferguson WP, Wilson TS, McCormick E: Gentamicin. J Antimicr Chemother 3: 213, 1977.CrossRefGoogle Scholar
  71. 71.
    Lewis SA, Altemeier WA: Emergence of clinical isolate of Staphylococcus aureus resistant to gentamicin and correlation of resistance with bacteriophage type. J Infect Dis 137: 314, 1978.PubMedCrossRefGoogle Scholar
  72. 72.
    Goatfredsen WO, Jahnsen S, Lorck H, Roholt K, Tybring L: Fusidic acid; a new antibiotic. Nature 193: 987, 1962a.CrossRefGoogle Scholar
  73. 73.
    Crosbie RB: Treatment of staphylococcal infections with ‘Fucidin’. Brit med JI: 788, 1963.CrossRefGoogle Scholar
  74. 74.
    Matsaniotis N, Messaritakis J. Anagnostakis D: Fusidic acid for staphylococcal infections in children. Brit Med JI: 564, 1967.CrossRefGoogle Scholar
  75. 75.
    Jensen K, Lassen HCA: Fulminating staphylococcal infections treated with Fucidin and penicillin or semisynthetic penicillin. Ann Intern Med 60 (5): 790, 1964.PubMedCrossRefGoogle Scholar
  76. 76.
    Norman AP: Fucidic acid in cystic fibrosis. Lancet ii: 216, 1967.Google Scholar
  77. 77.
    Lowbury EJL, Cason JS, Jackson DM, Miller RWS: Fucidin for staphylococcal infection of burns. Lancet ii: 478, 1962.CrossRefGoogle Scholar
  78. 78.
    Jensen KA, Klaer I: Fucidin. A study on problems of resistance I Acta Pathol Microbiol Scand 60 (2): 271, 1964.Google Scholar
  79. 79.
    Evans RJ, Waterworth PM: Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistance. J Clin Pathol 19: 555, 1966.PubMedCrossRefGoogle Scholar
  80. 80.
    Chopra I, Bennett P, Lacey RW: A variety of staphylococcal plasmids present as multiple copies. J Gen Microbiol 79: 343, 1973.PubMedCrossRefGoogle Scholar
  81. 81.
    Lacey RW, Rosdahl VT: An unusual ‘penicillinase plasmid’ in Staphylococcus aureus. Evidence for its transfer under natural conditions. J Med Microbiol 7: 1, 1974.PubMedCrossRefGoogle Scholar
  82. 82.
    Ayliffe GAJ, Green W, Livingston R, Lowbury EJL: Antibiotic resistant Staphylococcus aureus in dermatology and burn wards. J Clin Pathol 30: 40, 1977.PubMedCrossRefGoogle Scholar
  83. 83.
    Naidoo J, Noble WC: Acquisition of antibiotic resistance by Staphylococcus aureus in skin patients. J Clin Pathol 31: 1187, 1978.PubMedCrossRefGoogle Scholar
  84. 84.
    Ayliffe GAJ, Lilly HA, Lowbury EJL: Decline of the hospital staphylococcus? Lancet i: 538, 1979.CrossRefGoogle Scholar
  85. 85.
    Darrell JH, Garrod LP, Waterworth PM: Trimethoprim: Laboratory and clinical studies. J Clin Pathol 21: 202, 1968.PubMedCrossRefGoogle Scholar
  86. 86.
    Lewis EL, Anderson JD, Lacey RW: A reappraisal of the antibacterial action of cotrimoxazole in vitro. J Clin Pathol 27: 87, 1974.PubMedCrossRefGoogle Scholar
  87. 87.
    Fleming MP, Datta N, Grünberg RN: Trimethoprim resistance determined by R factors. Brit Med J 1: 726, 1972.PubMedCrossRefGoogle Scholar
  88. 88.
    Amyes SGB, Emmerson AM, Smith JT: R-factor mediated trimethoprim resistance: result of two three-month clinical surveys. J Clin Pathol 31: 850, 1978.PubMedCrossRefGoogle Scholar
  89. 89.
    Nakhla LS: Genetic determinants of trimethoprim resistance in a strain of Staphylococcus aureus. J Clin Pathol 26: 712, 1973.PubMedCrossRefGoogle Scholar
  90. 90.
    Lewis EL, Lacey RW: Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis. J Clin Pathol 26: 175, 1973.PubMedCrossRefGoogle Scholar
  91. 90.
    Chattopadhyay B: Co-trimoxazole resistant Staphylococcus aureus in hospital Practice. J Antimicr Chemother 3: 371, 1977.CrossRefGoogle Scholar
  92. 92.
    Nakhla LS: Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim. J Clin Pathol 25: 708, 1972.PubMedCrossRefGoogle Scholar
  93. 93.
    Seligman SJ: IN vitro susceptibility of methicillin— resistant Staphylococcus aureus to sulfamethoxazole and trimethoprim. J Infect Dis 128 (suppl): S543, 1973.CrossRefGoogle Scholar
  94. 94.
    Best BK, Best NH, Koval AV: Evidence for participation of autolysis in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob Ag Chemother 6: 825, 1974.CrossRefGoogle Scholar
  95. 95.
    Sabath LD, Laverdiere M, Wheeler N, Blazevic D, Wilkinson BJ: A new type of penicillin resistance of Staphylococcus aureus. Lancet i: 443, 1977.CrossRefGoogle Scholar
  96. 96.
    Bradley JJ, Mayhall CH, Dalton HP: Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicr Ag Chemother 13: 1052, 1978.CrossRefGoogle Scholar
  97. 97.
    Watanakunakorn C: Antibiotic-tolerant Staphylococcus aureus. J Antomicr Chemother 4: 561, 1978.CrossRefGoogle Scholar
  98. 98.
    Bradley HE, Weldy PL, Hodes DS: Tolerance in Staphylococcus aureus. Lancet i: 150, 1979.CrossRefGoogle Scholar
  99. 99.
    Bradley HE, Wetmur JG, Hodes DS: Tolerance in Staphylococcus aureus: Evidence for Bacteriophage Role. J Infect Dis 141: 233, 1980PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1981

Authors and Affiliations

  • R. P. Mouton

There are no affiliations available

Personalised recommendations